Cigna Group $CI Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. lifted its stake in shares of Cigna Group (NYSE:CI) by 1.9% in the 1st quarter, Holdings Channel reports. The institutional investor owned 310,580 shares of the health services provider’s stock after acquiring an additional 5,844 shares during the quarter. Principal Financial Group Inc.’s holdings in Cigna Group were worth $82,847,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. raised its stake in Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after acquiring an additional 414,834 shares in the last quarter. State Street Corp boosted its stake in Cigna Group by 1.8% in the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after acquiring an additional 224,122 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after purchasing an additional 903,334 shares during the last quarter. Dodge & Cox increased its position in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares in the last quarter. Finally, GQG Partners LLC increased its position in shares of Cigna Group by 14.3% during the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CI. Barclays cut Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $310.00 to $304.00 in a research report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and cut their price target for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Royal Bank Of Canada boosted their price objective on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Guggenheim lifted their target price on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $338.80.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Cigna Group Stock Performance

Shares of CI stock opened at $283.06 on Friday. The stock’s 50-day moving average price is $286.81 and its 200 day moving average price is $280.39. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $74.88 billion, a PE ratio of 12.00, a price-to-earnings-growth ratio of 1.15 and a beta of 0.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same period last year, the firm earned $6.74 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio is 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.